Radiopharmaceutical biotech Radionetics in fundraising mode with $54.2M so far
Radionetics Oncology is in the midst of a fundraising drive worth $68.7 million, with the California-based company having raised $54.2 million so far, per an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.